Lista de obras - Lubos Petruzelka - Dominio Público Uruguay

31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): late breaking abstracts: National Harbor, MD, USA. 9-13 November 2016.

artículo científico publicado en 2016

31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part one

artículo científico publicado en 2016

A phase I study of pemetrexed (ALIMTA) and cyclophosphamide in patients with locally advanced or metastatic breast cancer

artículo científico publicado en 2006

Activity of fulvestrant in HER2-overexpressing advanced breast cancer

artículo científico publicado en 2009

Adenocarcinoma of the lung among women: risk associated with smoking, prior lung disease, diet and menstrual and pregnancy history

artículo científico publicado en 2003

Analysis of human blood plasma and hen egg white by chiroptical spectroscopic methods (ECD, VCD, ROA).

artículo científico publicado en 2013

Bevacizumab plus paclitaxel versus bevacizumab plus capecitabine as first-line treatment for HER2-negative metastatic breast cancer (TURANDOT): primary endpoint results of a randomised, open-label, non-inferiority, phase 3 trial.

artículo científico publicado en 2016

Breast cancer characteristics-comparison of preoperative and postoperative values.

artículo científico publicado en 2013

Breast cancer risk assessment in the Czech female population--an adjustment of the original Gail model.

artículo científico publicado en 2005

Cellular and humoral immunodeficiency in breast cancer patients resistant to hormone therapy

artículo científico publicado en 2014

Clinical Performance of the Consensus Immunoscore in Colon Cancer in the Asian Population from the Multicenter International SITC Study

artículo científico publicado en 2022

Comparing duration of response and duration of clinical benefit between fulvestrant treatment groups in the CONFIRM trial: application of new methodology.

artículo científico publicado en 2013

Comparison of immunohistochemistry, four in situ hybridization methods and quantitative polymerase chain reaction for the molecular diagnosis of HER2 status in gastric cancer: a study of 55 cases.

artículo científico publicado en 2014

Concurrent chemoradiotherapy in locally advanced non-small cell lung cancer—Prognostic factors and reasons for treatment failure in group of patients 1996–2008

article by Milada Zemanova et al published June 2012 in Lung Cancer

Concurrent versus sequential chemoradiotherapy with cisplatin and vinorelbine in locally advanced non-small cell lung cancer: a randomized study

artículo científico publicado en 2004

Dietary habits and lung cancer risk among non-smoking women

artículo científico publicado en 2004

Final overall survival: fulvestrant 500 mg vs 250 mg in the randomized CONFIRM trial

artículo científico publicado en 2013

Fulvestrant in postmenopausal women with metastatic breast cancer progressing on prior endocrine therapy — results from an expanded access programme

Gemcitabine in locally advanced and metastatic non-small cell lung cancer: the Central European phase II study

artículo científico publicado en 1998

Gemcitabine monotherapy in patients with locally advanced or metastatic pancreatic cancer: a prospective observational study

artículo científico publicado en 2003

Gemcitabine plus cisplatin vs. gemcitabine plus carboplatin in stage IIIb and IV non-small cell lung cancer: a phase III randomized trial

artículo científico publicado en 2003

Growth/differentiation factor 15 (GDF-15) as new potential serum marker in patients with metastatic colorectal cancer

artículo científico publicado en 2018

High proportion of recurrent germline mutations in the BRCA1 gene in breast and ovarian cancer patients from the Prague area

artículo científico publicado en 2005

Higher efficacy of letrozole in combination with trastuzumab compared to letrozole monotherapy as first-line treatment in patients with HER2-positive, hormone-receptor-positive metastatic breast cancer - results of the eLEcTRA trial.

artículo científico publicado en 2011

Highlights from the 7th central European lung cancer conference

artículo científico publicado en 2002

International validation of the consensus Immunoscore for the classification of colon cancer: a prognostic and accuracy study

artículo científico publicado en 2018

Isolated Perfusion of the Upper Extremity with TNF-α – Double Venous Cannulation

artículo científico publicado en 2017

KIT receptor is expressed in more than 50% of early-stage malignant melanoma: a retrospective study of 261 patients

artículo científico publicado en 2005

Lessons from the ("Iressa" Expanded Access Programme: gefitinib in special non-small-cell lung cancer patient populations.

artículo científico publicado en 2003

Local treatment of hand-foot syndrome with uridine/thymidine: in vitro appraisal on a human keratinocyte cell line HaCaT

artículo científico publicado en 2012

Long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years after diagnosis of oestrogen receptor-positive breast cancer: ATLAS, a randomised trial

artículo científico publicado en 2013

Lung cancer risk among Czech women: a case-control study.

artículo científico publicado en 2002

MABp1 as a novel antibody treatment for advanced colorectal cancer: a randomised, double-blind, placebo-controlled, phase 3 study

artículo científico publicado en 2017

Mammaglobin A, a novel marker of minimal residual disease in early stages breast cancer

Migrastatics-Anti-metastatic and Anti-invasion Drugs: Promises and Challenges. ⬇️

artículo científico publicado en 2017

Molecular characterization and heterogeneity of circulating tumor cells in breast cancer.

artículo científico publicado en 2017

Molecular pathological predictive diagnostics in a patient with non-small cell lung cancer treated with crizotinib therapy: A case report

artículo científico publicado en 2017

Multicenter International Society for Immunotherapy of Cancer Study of the Consensus Immunoscore for the Prediction of Survival and Response to Chemotherapy in Stage III Colon Cancer

artículo científico publicado en 2020

Mutations of the BRCA1 gene in hereditary breast and ovarian cancer in the Czech Republic.

artículo científico publicado en 2003

Optimizing treatment for patients with metastatic renal cell carcinoma in the Central and Eastern European region.

artículo científico

P-978 Geftinib (ZD 1839, Iressa®) in treatment of advanced non-small cell lung cancers — one institutional experience on an expanded access program

PET/CT significance for planning radiotherapy of head and neck cancer.

artículo científico

Phase II study on the efficacy and safety of Lapatinib administered beyond disease progression and combined with vinorelbine in HER-2/neu- positive advanced breast cancer: results of the CECOG LaVie trial.

artículo científico publicado en 2016

Plasma fatty acid composition in patients with pancreatic cancer: correlations to clinical parameters

artículo científico publicado en 2012

Population-based study of BRCA1/2 mutations: family history based criteria identify minority of mutation carriers

artículo científico publicado en 2010

Postoperative radiochemotherapy with weekly cisplatin in patients with head and neck cancer single-institution outcome analysis

artículo científico publicado en 2012

Predicting axillary sentinel node status in patients with primary breast cancer.

artículo científico publicado en 2013

Predictive factors for the presence of tumor cells in bone marrow and peripheral blood in breast cancer patients

artículo científico publicado en 2015

Presentation, management and outcome of 32 patients with pregnancy-associated breast cancer: a matched controlled study

artículo científico publicado en 2009

Prospective non-randomized study of preoperative concurrent platinum plus 5-fluorouracil-based chemoradiotherapy with or without paclitaxel in esophageal cancer patients: long-term follow-up

artículo científico publicado en 2009

Randomized, double-blind, multicenter trial comparing two doses of arzoxifene (LY353381) in hormone-sensitive advanced or metastatic breast cancer patients.

artículo científico publicado en 2003

Receptor for Advanced Glycation End Products (RAGE)—Soluble Form (sRAGE) and Gene Polymorphisms in Patients with Breast Cancer

article

Regorafenib in the Real-Life Clinical Practice: Data from the Czech Registry.

artículo científico publicado en 2016

Results of the CONFIRM phase III trial comparing fulvestrant 250 mg with fulvestrant 500 mg in postmenopausal women with estrogen receptor-positive advanced breast cancer.

artículo científico publicado en 2010

Second consensus on medical treatment of metastatic breast cancer

artículo científico publicado en 2006

Selecting first-line bevacizumab-containing therapy for advanced breast cancer: TURANDOT risk factor analyses

artículo científico publicado en 2014

Sentinel lymph node biopsy in breast cancer patients treated with neoadjuvant chemotherapy.

artículo científico publicado en 2011

Serum adiponectin relates to shortened overall survival in men with squamous cell esophageal cancer treated with preoperative concurrent chemoradiotherapy: a pilot study

artículo científico publicado en 2014

Symptomatic control of hypoglycaemia with prednisone in refractory metastatic pancreatic insulinoma

artículo científico publicado en 2005

The CHEK2 c.1100delC germline mutation rarely contributes to breast cancer development in the Czech Republic

artículo científico publicado en 2005

The Inclusion of a Gemcitabine + Nab-paclitaxel Regimen as a 2nd Line Treatment for Advanced Pancreatic Cancer - First Experience

artículo científico publicado en 2017

The minimizing of fluorescence background in Raman optical activity and Raman spectra of human blood plasma

artículo científico publicado en 2014

The potential of chiroptical and vibrational spectroscopy of blood plasma for the discrimination between colon cancer patients and the control group

article

Third consensus on medical treatment of metastatic breast cancer.

artículo científico publicado en 2009

Treatment of locally advanced pancreatic cancer by percutaneous and intraoperative irreversible electroporation: general hospital cancer center experience

artículo científico publicado en 2016

Trefoil factor family (TFF) proteins as potential serum biomarkers in patients with metastatic colorectal cancer.

artículo científico publicado en 2015

Vinorelbine plus trastuzumab combination as first-line therapy for HER 2-positive metastatic breast cancer patients: an international phase II trial.

artículo científico publicado en 2006

Lista de obras de Lubos Petruzelka

31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): late breaking abstracts: National Harbor, MD, USA. 9-13 November 2016.

31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part one

A phase I study of pemetrexed (ALIMTA) and cyclophosphamide in patients with locally advanced or metastatic breast cancer

Activity of fulvestrant in HER2-overexpressing advanced breast cancer

Adenocarcinoma of the lung among women: risk associated with smoking, prior lung disease, diet and menstrual and pregnancy history

Analysis of human blood plasma and hen egg white by chiroptical spectroscopic methods (ECD, VCD, ROA).

Bevacizumab plus paclitaxel versus bevacizumab plus capecitabine as first-line treatment for HER2-negative metastatic breast cancer (TURANDOT): primary endpoint results of a randomised, open-label, non-inferiority, phase 3 trial.

Breast cancer characteristics-comparison of preoperative and postoperative values.

Breast cancer risk assessment in the Czech female population--an adjustment of the original Gail model.

Cellular and humoral immunodeficiency in breast cancer patients resistant to hormone therapy

Clinical Performance of the Consensus Immunoscore in Colon Cancer in the Asian Population from the Multicenter International SITC Study

Comparing duration of response and duration of clinical benefit between fulvestrant treatment groups in the CONFIRM trial: application of new methodology.

Comparison of immunohistochemistry, four in situ hybridization methods and quantitative polymerase chain reaction for the molecular diagnosis of HER2 status in gastric cancer: a study of 55 cases.

Concurrent chemoradiotherapy in locally advanced non-small cell lung cancer—Prognostic factors and reasons for treatment failure in group of patients 1996–2008

Concurrent versus sequential chemoradiotherapy with cisplatin and vinorelbine in locally advanced non-small cell lung cancer: a randomized study

Dietary habits and lung cancer risk among non-smoking women

Final overall survival: fulvestrant 500 mg vs 250 mg in the randomized CONFIRM trial

Fulvestrant in postmenopausal women with metastatic breast cancer progressing on prior endocrine therapy — results from an expanded access programme

Gemcitabine in locally advanced and metastatic non-small cell lung cancer: the Central European phase II study

Gemcitabine monotherapy in patients with locally advanced or metastatic pancreatic cancer: a prospective observational study

Gemcitabine plus cisplatin vs. gemcitabine plus carboplatin in stage IIIb and IV non-small cell lung cancer: a phase III randomized trial

Growth/differentiation factor 15 (GDF-15) as new potential serum marker in patients with metastatic colorectal cancer

High proportion of recurrent germline mutations in the BRCA1 gene in breast and ovarian cancer patients from the Prague area

Higher efficacy of letrozole in combination with trastuzumab compared to letrozole monotherapy as first-line treatment in patients with HER2-positive, hormone-receptor-positive metastatic breast cancer - results of the eLEcTRA trial.

Highlights from the 7th central European lung cancer conference

International validation of the consensus Immunoscore for the classification of colon cancer: a prognostic and accuracy study

Isolated Perfusion of the Upper Extremity with TNF-α – Double Venous Cannulation

KIT receptor is expressed in more than 50% of early-stage malignant melanoma: a retrospective study of 261 patients

Lessons from the ("Iressa" Expanded Access Programme: gefitinib in special non-small-cell lung cancer patient populations.

Local treatment of hand-foot syndrome with uridine/thymidine: in vitro appraisal on a human keratinocyte cell line HaCaT

Long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years after diagnosis of oestrogen receptor-positive breast cancer: ATLAS, a randomised trial

Lung cancer risk among Czech women: a case-control study.

MABp1 as a novel antibody treatment for advanced colorectal cancer: a randomised, double-blind, placebo-controlled, phase 3 study

Mammaglobin A, a novel marker of minimal residual disease in early stages breast cancer

Migrastatics-Anti-metastatic and Anti-invasion Drugs: Promises and Challenges. ⬇️

Molecular characterization and heterogeneity of circulating tumor cells in breast cancer.

Molecular pathological predictive diagnostics in a patient with non-small cell lung cancer treated with crizotinib therapy: A case report

Multicenter International Society for Immunotherapy of Cancer Study of the Consensus Immunoscore for the Prediction of Survival and Response to Chemotherapy in Stage III Colon Cancer

Mutations of the BRCA1 gene in hereditary breast and ovarian cancer in the Czech Republic.

Optimizing treatment for patients with metastatic renal cell carcinoma in the Central and Eastern European region.

P-978 Geftinib (ZD 1839, Iressa®) in treatment of advanced non-small cell lung cancers — one institutional experience on an expanded access program

PET/CT significance for planning radiotherapy of head and neck cancer.

Phase II study on the efficacy and safety of Lapatinib administered beyond disease progression and combined with vinorelbine in HER-2/neu- positive advanced breast cancer: results of the CECOG LaVie trial.

Plasma fatty acid composition in patients with pancreatic cancer: correlations to clinical parameters

Population-based study of BRCA1/2 mutations: family history based criteria identify minority of mutation carriers

Postoperative radiochemotherapy with weekly cisplatin in patients with head and neck cancer single-institution outcome analysis

Predicting axillary sentinel node status in patients with primary breast cancer.

Predictive factors for the presence of tumor cells in bone marrow and peripheral blood in breast cancer patients

Presentation, management and outcome of 32 patients with pregnancy-associated breast cancer: a matched controlled study

Prospective non-randomized study of preoperative concurrent platinum plus 5-fluorouracil-based chemoradiotherapy with or without paclitaxel in esophageal cancer patients: long-term follow-up

Randomized, double-blind, multicenter trial comparing two doses of arzoxifene (LY353381) in hormone-sensitive advanced or metastatic breast cancer patients.

Receptor for Advanced Glycation End Products (RAGE)—Soluble Form (sRAGE) and Gene Polymorphisms in Patients with Breast Cancer

Regorafenib in the Real-Life Clinical Practice: Data from the Czech Registry.

Results of the CONFIRM phase III trial comparing fulvestrant 250 mg with fulvestrant 500 mg in postmenopausal women with estrogen receptor-positive advanced breast cancer.

Second consensus on medical treatment of metastatic breast cancer

Selecting first-line bevacizumab-containing therapy for advanced breast cancer: TURANDOT risk factor analyses

Sentinel lymph node biopsy in breast cancer patients treated with neoadjuvant chemotherapy.

Serum adiponectin relates to shortened overall survival in men with squamous cell esophageal cancer treated with preoperative concurrent chemoradiotherapy: a pilot study

Symptomatic control of hypoglycaemia with prednisone in refractory metastatic pancreatic insulinoma

The CHEK2 c.1100delC germline mutation rarely contributes to breast cancer development in the Czech Republic

The Inclusion of a Gemcitabine + Nab-paclitaxel Regimen as a 2nd Line Treatment for Advanced Pancreatic Cancer - First Experience

The minimizing of fluorescence background in Raman optical activity and Raman spectra of human blood plasma

The potential of chiroptical and vibrational spectroscopy of blood plasma for the discrimination between colon cancer patients and the control group

Third consensus on medical treatment of metastatic breast cancer.

Treatment of locally advanced pancreatic cancer by percutaneous and intraoperative irreversible electroporation: general hospital cancer center experience

Trefoil factor family (TFF) proteins as potential serum biomarkers in patients with metastatic colorectal cancer.

Vinorelbine plus trastuzumab combination as first-line therapy for HER 2-positive metastatic breast cancer patients: an international phase II trial.